DOCSLIB.ORG

Mouse Cyth1 Conditional Knockout Project (CRISPR/Cas9)

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Mouse Cyth1 Conditional Knockout Project (CRISPR/Cas9) https://www.alphaknockout.com Mouse Cyth1 Conditional Knockout Project (CRISPR/Cas9) Objective: To create a Cyth1 conditional knockout Mouse model (C57BL/6J) by CRISPR/Cas-mediated genome engineering. Strategy summary: The Cyth1 gene (NCBI Reference Sequence: NM_011180 ; Ensembl: ENSMUSG00000017132 ) is located on Mouse chromosome 11. 13 exons are identified, with the ATG start codon in exon 1 and the TGA stop codon in exon 13 (Transcript: ENSMUST00000106305). Exon 3 will be selected as conditional knockout region (cKO region). Deletion of this region should result in the loss of function of the Mouse Cyth1 gene. To engineer the targeting vector, homologous arms and cKO region will be generated by PCR using BAC clone RP24-370L14 as template. Cas9, gRNA and targeting vector will be co-injected into fertilized eggs for cKO Mouse production. The pups will be genotyped by PCR followed by sequencing analysis. Note: Mice homozygous for a gene trap allele exhibit normal brain morphology and long term potentiation. Mice homozygous for a knock-out allele exhibit decreased myelin sheath thickness due to hypomyelination. Exon 3 starts from about 8.88% of the coding region. The knockout of Exon 3 will result in frameshift of the gene. The size of intron 2 for 5'-loxP site insertion: 1153 bp, and the size of intron 3 for 3'-loxP site insertion: 6570 bp. The size of effective cKO region: ~565 bp. The cKO region does not have any other known gene. Page 1 of 8 https://www.alphaknockout.com Overview of the Targeting Strategy Wildtype allele gRNA region 5' gRNA region 3' 1 2 3 13 Targeting vector Targeted allele Constitutive KO allele (After Cre recombination) Legends Exon of mouse Cyth1 Homology arm cKO region loxP site Page 2 of 8 https://www.alphaknockout.com Overview of the Dot Plot Window size: 10 bp Forward Reverse Complement Sequence 12 Note: The sequence of homologous arms and cKO region is aligned with itself to determine if there are tandem repeats. No significant tandem repeat is found in the dot plot matrix. So this region is suitable for PCR screening or sequencing analysis. Overview of the GC Content Distribution Window size: 300 bp Sequence 12 Summary: Full Length(7065bp) | A(24.46% 1728) | C(24.06% 1700) | T(27.3% 1929) | G(24.18% 1708) Note: The sequence of homologous arms and cKO region is analyzed to determine the GC content. No significant high GC-content region is found. So this region is suitable for PCR screening or sequencing analysis. Page 3 of 8 https://www.alphaknockout.com BLAT Search Results (up) QUERY SCORE START END QSIZE IDENTITY CHROM STRAND START END SPAN ----------------------------------------------------------------------------------------------- browser details YourSeq 3000 1 3000 3000 100.0% chr11 - 118192712 118195711 3000 browser details YourSeq 121 2804 2993 3000 90.7% chr6 - 28288724 28289076 353 browser details YourSeq 121 2796 2931 3000 94.9% chr15 + 81701531 81701678 148 browser details YourSeq 115 2798 2932 3000 92.6% chr11 - 86482727 86482861 135 browser details YourSeq 114 2796 2932 3000 92.0% chr11 + 32111504 32111649 146 browser details YourSeq 113 2796 2932 3000 93.9% chrX + 132531256 132531405 150 browser details YourSeq 112 2800 2931 3000 90.0% chr2 - 167047094 167047222 129 browser details YourSeq 112 2798 2931 3000 91.8% chr11 - 82762521 82762654 134 browser details YourSeq 112 2796 2931 3000 91.2% chr9 + 57308258 57308393 136 browser details YourSeq 110 2804 2933 3000 92.4% chr19 + 19917178 19917307 130 browser details YourSeq 110 2798 2931 3000 91.1% chr15 + 37284003 37284136 134 browser details YourSeq 109 2810 2932 3000 92.7% chr5 - 139519205 139519326 122 browser details YourSeq 107 2804 2934 3000 90.9% chr9 - 121249161 121249291 131 browser details YourSeq 107 2800 2928 3000 91.5% chr2 - 69676794 69676922 129 browser details YourSeq 107 2798 2931 3000 90.3% chr10 + 70162215 70162350 136 browser details YourSeq 106 2809 2928 3000 94.2% chr5 - 28233443 28233562 120 browser details YourSeq 106 2809 2928 3000 94.2% chr6 + 119742070 119742189 120 browser details YourSeq 106 2809 2932 3000 91.1% chr10 + 7810841 7810963 123 browser details YourSeq 105 2800 2930 3000 90.1% chrX - 128364462 128364592 131 browser details YourSeq 105 2804 2930 3000 91.4% chr5 - 111246601 111246727 127 Note: The 3000 bp section upstream of Exon 3 is BLAT searched against the genome. No significant similarity is found. BLAT Search Results (down) QUERY SCORE START END QSIZE IDENTITY CHROM STRAND START END SPAN ----------------------------------------------------------------------------------------------- browser details YourSeq 3000 1 3000 3000 100.0% chr11 - 118189147 118192146 3000 browser details YourSeq 368 656 1055 3000 96.0% chr11 - 118191252 118191651 400 browser details YourSeq 368 496 895 3000 96.0% chr11 - 118191092 118191491 400 browser details YourSeq 222 816 1055 3000 96.3% chr11 - 118191412 118191651 240 browser details YourSeq 222 496 735 3000 96.3% chr11 - 118191092 118191331 240 browser details YourSeq 202 211 2519 3000 91.3% chr13 + 19762560 19996131 233572 browser details YourSeq 193 1728 2517 3000 92.2% chr11 + 46316585 46386134 69550 browser details YourSeq 174 496 683 3000 96.3% chr11 - 118191104 118191291 188 browser details YourSeq 162 2361 2996 3000 84.0% chr4 + 129386156 129386366 211 browser details YourSeq 147 2354 2526 3000 95.8% chrX - 166603120 166603315 196 browser details YourSeq 145 2357 2518 3000 95.7% chr15 - 102613978 102614144 167 browser details YourSeq 145 2357 2518 3000 95.1% chr15 + 82828957 82829119 163 browser details YourSeq 145 2359 2523 3000 91.4% chr13 + 113331205 113331366 162 browser details YourSeq 145 2357 2522 3000 94.6% chr1 + 60418516 60418688 173 browser details YourSeq 144 2363 2527 3000 94.6% chr15 - 61575595 61575892 298 browser details YourSeq 144 2354 2523 3000 91.2% chr14 - 31848753 31848917 165 browser details YourSeq 143 2358 2527 3000 93.5% chr1 - 192656864 192657166 303 browser details YourSeq 143 2354 2527 3000 93.3% chr2 + 30059688 30060188 501 browser details YourSeq 142 2359 2518 3000 92.5% chr19 - 45992537 45992694 158 browser details YourSeq 142 2358 2523 3000 94.4% chr8 + 59506608 59506779 172 Note: The 3000 bp section downstream of Exon 3 is BLAT searched against the genome. No significant similarity is found. Page 4 of 8 https://www.alphaknockout.com Gene and protein information: Cyth1 cytohesin 1 [ Mus musculus (house mouse) ] Gene ID: 19157, updated on 24-Oct-2019 Gene summary Official Symbol Cyth1 provided by MGI Official Full Name cytohesin 1 provided by MGI Primary source MGI:MGI:1334257 See related Ensembl:ENSMUSG00000017132 Gene type protein coding RefSeq status VALIDATED Organism Mus musculus Lineage Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae; Murinae; Mus; Mus Also known as CLM1; CTH-1; CYTIP; Pscd1 Expression Ubiquitous expression in cerebellum adult (RPKM 19.7), frontal lobe adult (RPKM 16.5) and 27 other tissues See more Orthologs human all Genomic context Location: 11; 11 E2 See Cyth1 in Genome Data Viewer Exon count: 18 Annotation release Status Assembly Chr Location 108 current GRCm38.p6 (GCF_000001635.26) 11 NC_000077.6 (118164166..118248616, complement) Build 37.2 previous assembly MGSCv37 (GCF_000001635.18) 11 NC_000077.5 (118025480..118109906, complement) Chromosome 11 - NC_000077.6 Page 5 of 8 https://www.alphaknockout.com Transcript information: This gene has 7 transcripts Gene: Cyth1 ENSMUSG00000017132 Description cytohesin 1 [Source:MGI Symbol;Acc:MGI:1334257] Gene Synonyms CLM1, CTH-1, Pscd1 Location Chromosome 11: 118,132,019-118,248,592 reverse strand. GRCm38:CM001004.2 About this gene This gene has 7 transcripts (splice variants), 259 orthologues, 15 paralogues, is a member of 1 Ensembl protein family and is associated with 2 phenotypes. Transcripts Name Transcript ID bp Protein Translation ID Biotype CCDS UniProt Flags Cyth1- ENSMUST00000106305.8 3179 398aa ENSMUSP00000101912.2 Protein CCDS48996 Q9QX11 TSL:1 204 coding GENCODE basic APPRIS ALT1 Cyth1- ENSMUST00000017276.13 3135 397aa ENSMUSP00000017276.7 Protein CCDS48997 Q8K3E8 TSL:1 201 coding Q9QX11 GENCODE basic APPRIS ALT1 Cyth1- ENSMUST00000106302.8 3119 400aa ENSMUSP00000101909.2 Protein CCDS48995 Q3TZ02 TSL:1 203 coding GENCODE basic APPRIS P4 Cyth1- ENSMUST00000100181.10 1592 460aa ENSMUSP00000097756.4 Protein - A2A517 CDS 5' 202 coding incomplete TSL:1 Cyth1- ENSMUST00000151165.1 363 99aa ENSMUSP00000114792.1 Protein - B1AQE4 CDS 3' 207 coding incomplete TSL:2 Cyth1- ENSMUST00000141243.7 545 No - lncRNA - - TSL:3 206 protein Cyth1- ENSMUST00000131115.1 355 No - lncRNA - - TSL:3 205 protein Page 6 of 8 https://www.alphaknockout.com 136.57 kb Forward strand 118.14Mb 118.16Mb 118.18Mb 118.20Mb 118.22Mb 118.24Mb Contigs AL591204.14 > AL591109.8 > AL591404.4 > Genes (Comprehensive set... < Dnah17-203protein coding < Cyth1-204protein coding < Dnah17-202protein coding < Cyth1-203protein coding < Dnah17-204protein coding < Cyth1-201protein coding < Cyth1-202protein coding < Gm24060-201snRNA < Gm11737-201processed pseudogene < Cyth1-206lncRNA < Cyth1-205lncRNA < Cyth1-207protein coding Regulatory Build 118.14Mb 118.16Mb 118.18Mb 118.20Mb 118.22Mb 118.24Mb Reverse strand 136.57 kb Regulation Legend CTCF Enhancer Open Chromatin Promoter Promoter Flank Gene Legend Protein Coding Ensembl protein coding merged Ensembl/Havana Non-Protein Coding pseudogene RNA gene Page 7 of 8 https://www.alphaknockout.com Transcript: ENSMUST00000106305 < Cyth1-204protein coding Reverse strand 84.43 kb ENSMUSP00000101... Coiled-coils (Ncoils) Superfamily Sec7 domain superfamily SSF50729 SMART Sec7 domain Pleckstrin homology domain Pfam Sec7 domain Pleckstrin homology domain PROSITE profiles Sec7 domain Pleckstrin homology domain PANTHER PTHR10663:SF340 PTHR10663 Gene3D 1.10.220.20 Sec7, C-terminal domain superfamily PH-like domain superfamily CDD Sec7 domain cd01252 All sequence SNPs/i... Sequence variants (dbSNP and all other sources) Variant Legend synonymous variant Scale bar 0 40 80 120 160 200 240 280 320 398 We wish to acknowledge the following valuable scientific information resources: Ensembl, MGI, NCBI, UCSC. Page 8 of 8.
Load more

Recommended publications
  • Anti-ARL4A Antibody (ARG41291)
    Product datasheet [email protected] ARG41291 Package: 100 μl anti-ARL4A antibody Store at: -20°C Summary Product Description Rabbit Polyclonal antibody recognizes ARL4A Tested Reactivity Hu, Ms, Rat Tested Application ICC/IF, IHC-P Host Rabbit Clonality Polyclonal Isotype IgG Target Name ARL4A Antigen Species Human Immunogen Recombinant fusion protein corresponding to aa. 121-200 of Human ARL4A (NP_001032241.1). Conjugation Un-conjugated Alternate Names ARL4; ADP-ribosylation factor-like protein 4A Application Instructions Application table Application Dilution ICC/IF 1:50 - 1:200 IHC-P 1:50 - 1:200 Application Note * The dilutions indicate recommended starting dilutions and the optimal dilutions or concentrations should be determined by the scientist. Calculated Mw 23 kDa Properties Form Liquid Purification Affinity purified. Buffer PBS (pH 7.3), 0.02% Sodium azide and 50% Glycerol. Preservative 0.02% Sodium azide Stabilizer 50% Glycerol Storage instruction For continuous use, store undiluted antibody at 2-8°C for up to a week. For long-term storage, aliquot and store at -20°C. Storage in frost free freezers is not recommended. Avoid repeated freeze/thaw cycles. Suggest spin the vial prior to opening. The antibody solution should be gently mixed before use. Note For laboratory research only, not for drug, diagnostic or other use. www.arigobio.com 1/2 Bioinformation Gene Symbol ARL4A Gene Full Name ADP-ribosylation factor-like 4A Background ADP-ribosylation factor-like 4A is a member of the ADP-ribosylation factor family of GTP-binding proteins. ARL4A is similar to ARL4C and ARL4D and each has a nuclear localization signal and an unusually high guaninine nucleotide exchange rate.
    [Show full text]
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • Targeting PH Domain Proteins for Cancer Therapy
    The Texas Medical Center Library DigitalCommons@TMC The University of Texas MD Anderson Cancer Center UTHealth Graduate School of The University of Texas MD Anderson Cancer Biomedical Sciences Dissertations and Theses Center UTHealth Graduate School of (Open Access) Biomedical Sciences 12-2018 Targeting PH domain proteins for cancer therapy Zhi Tan Follow this and additional works at: https://digitalcommons.library.tmc.edu/utgsbs_dissertations Part of the Bioinformatics Commons, Medicinal Chemistry and Pharmaceutics Commons, Neoplasms Commons, and the Pharmacology Commons Recommended Citation Tan, Zhi, "Targeting PH domain proteins for cancer therapy" (2018). The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences Dissertations and Theses (Open Access). 910. https://digitalcommons.library.tmc.edu/utgsbs_dissertations/910 This Dissertation (PhD) is brought to you for free and open access by the The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences at DigitalCommons@TMC. It has been accepted for inclusion in The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences Dissertations and Theses (Open Access) by an authorized administrator of DigitalCommons@TMC. For more information, please contact [email protected]. TARGETING PH DOMAIN PROTEINS FOR CANCER THERAPY by Zhi Tan Approval page APPROVED: _____________________________________________ Advisory Professor, Shuxing Zhang, Ph.D. _____________________________________________
    [Show full text]
  • SUPPLEMENTARY APPENDIX Inflammation Regulates Long Non-Coding RNA-PTTG1-1:1 in Myeloid Leukemia
    SUPPLEMENTARY APPENDIX Inflammation regulates long non-coding RNA-PTTG1-1:1 in myeloid leukemia Sébastien Chateauvieux, 1,2 Anthoula Gaigneaux, 1° Déborah Gérard, 1 Marion Orsini, 1 Franck Morceau, 1 Barbora Orlikova-Boyer, 1,2 Thomas Farge, 3,4 Christian Récher, 3,4,5 Jean-Emmanuel Sarry, 3,4 Mario Dicato 1 and Marc Diederich 2 °Current address: University of Luxembourg, Faculty of Science, Technology and Communication, Life Science Research Unit, Belvaux, Luxemburg. 1Laboratoire de Biologie Moléculaire et Cellulaire du Cancer, Hôpital Kirchberg, Luxembourg, Luxembourg; 2College of Pharmacy, Seoul National University, Gwanak-gu, Seoul, Korea; 3Cancer Research Center of Toulouse, UMR 1037 INSERM/ Université Toulouse III-Paul Sabatier, Toulouse, France; 4Université Toulouse III Paul Sabatier, Toulouse, France and 5Service d’Hématologie, Centre Hospitalier Universitaire de Toulouse, Institut Universitaire du Cancer de Toulouse Oncopôle, Toulouse, France Correspondence: MARC DIEDERICH - [email protected] doi:10.3324/haematol.2019.217281 Supplementary data Inflammation regulates long non-coding RNA-PTTG1-1:1 in myeloid leukemia Sébastien Chateauvieux1,2, Anthoula Gaigneaux1*, Déborah Gérard1, Marion Orsini1, Franck Morceau1, Barbora Orlikova-Boyer1,2, Thomas Farge3,4, Christian Récher3,4,5, Jean-Emmanuel Sarry3,4, Mario Dicato1 and Marc Diederich2 1 Laboratoire de Biologie Moléculaire et Cellulaire du Cancer, Hôpital Kirchberg, 9, rue Edward Steichen, 2540 Luxembourg, Luxemburg; 2 College of Pharmacy, Seoul National University, 1 Gwanak-ro,
    [Show full text]
  • Gene Ontology Functional Annotations and Pleiotropy
    Network based analysis of genetic disease associations Sarah Gilman Submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy under the Executive Committee of the Graduate School of Arts and Sciences COLUMBIA UNIVERSITY 2014 © 2013 Sarah Gilman All Rights Reserved ABSTRACT Network based analysis of genetic disease associations Sarah Gilman Despite extensive efforts and many promising early findings, genome-wide association studies have explained only a small fraction of the genetic factors contributing to common human diseases. There are many theories about where this “missing heritability” might lie, but increasingly the prevailing view is that common variants, the target of GWAS, are not solely responsible for susceptibility to common diseases and a substantial portion of human disease risk will be found among rare variants. Relatively new, such variants have not been subject to purifying selection, and therefore may be particularly pertinent for neuropsychiatric disorders and other diseases with greatly reduced fecundity. Recently, several researchers have made great progress towards uncovering the genetics behind autism and schizophrenia. By sequencing families, they have found hundreds of de novo variants occurring only in affected individuals, both large structural copy number variants and single nucleotide variants. Despite studying large cohorts there has been little recurrence among the genes implicated suggesting that many hundreds of genes may underlie these complex phenotypes. The question
    [Show full text]
  • Identification of Fusion Genes in Breast Cancer by Paired-End RNA
    Edgren et al. Genome Biology 2011, 12:R6 http://genomebiology.com/2011/12/1/R6 RESEARCH Open Access Identification of fusion genes in breast cancer by paired-end RNA-sequencing Henrik Edgren1†, Astrid Murumagi1†, Sara Kangaspeska1†, Daniel Nicorici1, Vesa Hongisto2, Kristine Kleivi2,3, Inga H Rye3, Sandra Nyberg2, Maija Wolf1, Anne-Lise Borresen-Dale1,4, Olli Kallioniemi1* Abstract Background: Until recently, chromosomal translocations and fusion genes have been an underappreciated class of mutations in solid tumors. Next-generation sequencing technologies provide an opportunity for systematic characterization of cancer cell transcriptomes, including the discovery of expressed fusion genes resulting from underlying genomic rearrangements. Results: We applied paired-end RNA-seq to identify 24 novel and 3 previously known fusion genes in breast cancer cells. Supported by an improved bioinformatic approach, we had a 95% success rate of validating gene fusions initially detected by RNA-seq. Fusion partner genes were found to contribute promoters (5’ UTR), coding sequences and 3’ UTRs. Most fusion genes were associated with copy number transitions and were particularly common in high-level DNA amplifications. This suggests that fusion events may contribute to the selective advantage provided by DNA amplifications and deletions. Some of the fusion partner genes, such as GSDMB in the TATDN1-GSDMB fusion and IKZF3 in the VAPB-IKZF3 fusion, were only detected as a fusion transcript, indicating activation of a dormant gene by the fusion event. A number of fusion gene partners have either been previously observed in oncogenic gene fusions, mostly in leukemias, or otherwise reported to be oncogenic. RNA interference-mediated knock-down of the VAPB-IKZF3 fusion gene indicated that it may be necessary for cancer cell growth and survival.
    [Show full text]
  • Identification of Genomic Targets of Krüppel-Like Factor 9 in Mouse Hippocampal
    Identification of Genomic Targets of Krüppel-like Factor 9 in Mouse Hippocampal Neurons: Evidence for a role in modulating peripheral circadian clocks by Joseph R. Knoedler A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy (Neuroscience) in the University of Michigan 2016 Doctoral Committee: Professor Robert J. Denver, Chair Professor Daniel Goldman Professor Diane Robins Professor Audrey Seasholtz Associate Professor Bing Ye ©Joseph R. Knoedler All Rights Reserved 2016 To my parents, who never once questioned my decision to become the other kind of doctor, And to Lucy, who has pushed me to be a better person from day one. ii Acknowledgements I have a huge number of people to thank for having made it to this point, so in no particular order: -I would like to thank my adviser, Dr. Robert J. Denver, for his guidance, encouragement, and patience over the last seven years; his mentorship has been indispensable for my growth as a scientist -I would also like to thank my committee members, Drs. Audrey Seasholtz, Dan Goldman, Diane Robins and Bing Ye, for their constructive feedback and their willingness to meet in a frequently cold, windowless room across campus from where they work -I am hugely indebted to Pia Bagamasbad and Yasuhiro Kyono for teaching me almost everything I know about molecular biology and bioinformatics, and to Arasakumar Subramani for his tireless work during the home stretch to my dissertation -I am grateful for the Neuroscience Program leadership and staff, in particular
    [Show full text]
  • UC San Diego Electronic Theses and Dissertations
    UC San Diego UC San Diego Electronic Theses and Dissertations Title Cardiac Stretch-Induced Transcriptomic Changes are Axis-Dependent Permalink https://escholarship.org/uc/item/7m04f0b0 Author Buchholz, Kyle Stephen Publication Date 2016 Peer reviewed|Thesis/dissertation eScholarship.org Powered by the California Digital Library University of California UNIVERSITY OF CALIFORNIA, SAN DIEGO Cardiac Stretch-Induced Transcriptomic Changes are Axis-Dependent A dissertation submitted in partial satisfaction of the requirements for the degree Doctor of Philosophy in Bioengineering by Kyle Stephen Buchholz Committee in Charge: Professor Jeffrey Omens, Chair Professor Andrew McCulloch, Co-Chair Professor Ju Chen Professor Karen Christman Professor Robert Ross Professor Alexander Zambon 2016 Copyright Kyle Stephen Buchholz, 2016 All rights reserved Signature Page The Dissertation of Kyle Stephen Buchholz is approved and it is acceptable in quality and form for publication on microfilm and electronically: Co-Chair Chair University of California, San Diego 2016 iii Dedication To my beautiful wife, Rhia. iv Table of Contents Signature Page ................................................................................................................... iii Dedication .......................................................................................................................... iv Table of Contents ................................................................................................................ v List of Figures ...................................................................................................................
    [Show full text]
  • An Evaluation of Cancer Subtypes and Glioma Stem Cell Characterisation Unifying Tumour Transcriptomic Features with Cell Line Expression and Chromatin Accessibility
    An evaluation of cancer subtypes and glioma stem cell characterisation Unifying tumour transcriptomic features with cell line expression and chromatin accessibility Ewan Roderick Johnstone EMBL-EBI, Darwin College University of Cambridge This dissertation is submitted for the degree of Doctor of Philosophy Darwin College December 2016 Dedicated to Klaudyna. Declaration • I hereby declare that except where specific reference is made to the work of others, the contents of this dissertation are original and have not been submitted in whole or in part for consideration for any other degree or qualification in this, or any other university. • This dissertation is my own work and contains nothing which is the outcome of work done in collaboration with others, except as specified in the text and Acknowledge- ments. • This dissertation is typeset in LATEX using one-and-a-half spacing, contains fewer than 60,000 words including appendices, footnotes, tables and equations and has fewer than 150 figures. Ewan Roderick Johnstone December 2016 Acknowledgements This work was funded by the Biotechnology and Biological Sciences Research Council (BBSRC, Ref:1112564) and supported by the European Molecular Biology Laboratory (EMBL) and its outstation, the European Bioinformatics Institute (EBI). I have many people to thank for assistance in preparing this thesis. First and foremost I must thank my supervisor, Paul Bertone for his support and willingness to take me on as a student. My thanks are also extended to present and past members of the Bertone group, particularly Pär Engström and Remco Loos who have provided a great deal of guidance over the course of my studentship.
    [Show full text]
  • Autocrine IFN Signaling Inducing Profibrotic Fibroblast Responses By
    Downloaded from http://www.jimmunol.org/ by guest on September 23, 2021 Inducing is online at: average * The Journal of Immunology , 11 of which you can access for free at: 2013; 191:2956-2966; Prepublished online 16 from submission to initial decision 4 weeks from acceptance to publication August 2013; doi: 10.4049/jimmunol.1300376 http://www.jimmunol.org/content/191/6/2956 A Synthetic TLR3 Ligand Mitigates Profibrotic Fibroblast Responses by Autocrine IFN Signaling Feng Fang, Kohtaro Ooka, Xiaoyong Sun, Ruchi Shah, Swati Bhattacharyya, Jun Wei and John Varga J Immunol cites 49 articles Submit online. Every submission reviewed by practicing scientists ? is published twice each month by Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts http://jimmunol.org/subscription Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html http://www.jimmunol.org/content/suppl/2013/08/20/jimmunol.130037 6.DC1 This article http://www.jimmunol.org/content/191/6/2956.full#ref-list-1 Information about subscribing to The JI No Triage! Fast Publication! Rapid Reviews! 30 days* Why • • • Material References Permissions Email Alerts Subscription Supplementary The Journal of Immunology The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2013 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. This information is current as of September 23, 2021. The Journal of Immunology A Synthetic TLR3 Ligand Mitigates Profibrotic Fibroblast Responses by Inducing Autocrine IFN Signaling Feng Fang,* Kohtaro Ooka,* Xiaoyong Sun,† Ruchi Shah,* Swati Bhattacharyya,* Jun Wei,* and John Varga* Activation of TLR3 by exogenous microbial ligands or endogenous injury-associated ligands leads to production of type I IFN.
    [Show full text]
  • Mrna Expression in Human Leiomyoma and Eker Rats As Measured by Microarray Analysis
    Table 3S: mRNA Expression in Human Leiomyoma and Eker Rats as Measured by Microarray Analysis Human_avg Rat_avg_ PENG_ Entrez. Human_ log2_ log2_ RAPAMYCIN Gene.Symbol Gene.ID Gene Description avg_tstat Human_FDR foldChange Rat_avg_tstat Rat_FDR foldChange _DN A1BG 1 alpha-1-B glycoprotein 4.982 9.52E-05 0.68 -0.8346 0.4639 -0.38 A1CF 29974 APOBEC1 complementation factor -0.08024 0.9541 -0.02 0.9141 0.421 0.10 A2BP1 54715 ataxin 2-binding protein 1 2.811 0.01093 0.65 0.07114 0.954 -0.01 A2LD1 87769 AIG2-like domain 1 -0.3033 0.8056 -0.09 -3.365 0.005704 -0.42 A2M 2 alpha-2-macroglobulin -0.8113 0.4691 -0.03 6.02 0 1.75 A4GALT 53947 alpha 1,4-galactosyltransferase 0.4383 0.7128 0.11 6.304 0 2.30 AACS 65985 acetoacetyl-CoA synthetase 0.3595 0.7664 0.03 3.534 0.00388 0.38 AADAC 13 arylacetamide deacetylase (esterase) 0.569 0.6216 0.16 0.005588 0.9968 0.00 AADAT 51166 aminoadipate aminotransferase -0.9577 0.3876 -0.11 0.8123 0.4752 0.24 AAK1 22848 AP2 associated kinase 1 -1.261 0.2505 -0.25 0.8232 0.4689 0.12 AAMP 14 angio-associated, migratory cell protein 0.873 0.4351 0.07 1.656 0.1476 0.06 AANAT 15 arylalkylamine N-acetyltransferase -0.3998 0.7394 -0.08 0.8486 0.456 0.18 AARS 16 alanyl-tRNA synthetase 5.517 0 0.34 8.616 0 0.69 AARS2 57505 alanyl-tRNA synthetase 2, mitochondrial (putative) 1.701 0.1158 0.35 0.5011 0.6622 0.07 AARSD1 80755 alanyl-tRNA synthetase domain containing 1 4.403 9.52E-05 0.52 1.279 0.2609 0.13 AASDH 132949 aminoadipate-semialdehyde dehydrogenase -0.8921 0.4247 -0.12 -2.564 0.02993 -0.32 AASDHPPT 60496 aminoadipate-semialdehyde
    [Show full text]
  • PSCDBP (CYTIP) Rabbit Polyclonal Antibody – TA308371 | Origene
    OriGene Technologies, Inc. 9620 Medical Center Drive, Ste 200 Rockville, MD 20850, US Phone: +1-888-267-4436 [email protected] EU: [email protected] CN: [email protected] Product datasheet for TA308371 PSCDBP (CYTIP) Rabbit Polyclonal Antibody Product data: Product Type: Primary Antibodies Applications: WB Recommended Dilution: WB:1:500-1:3000 Reactivity: Human Host: Rabbit Isotype: IgG Clonality: Polyclonal Immunogen: Synthetic peptide corresponding to a region within amino acids 1 and 44 of PSCDBP (Uniprot ID#O60759) Formulation: 1XPBS, 10% Glycerol (pH7). 0.01% Thimerosal was added as a preservative. Concentration: lot specific Purification: Purified by antigen-affinity chromatography. Conjugation: Unconjugated Storage: Store at -20°C as received. Stability: Stable for 12 months from date of receipt. Predicted Protein Size: 40 kDa Gene Name: cytohesin 1 interacting protein Database Link: NP_004279 Entrez Gene 9595 Human O60759 Background: The protein encoded by this gene contains 2 leucine zipper domains and a putative C- terminal nuclear targeting signal, but does not have any hydrophobic regions. This protein is expressed weakly in resting NK and T cells. The encoded protein modulates the activation of ARF genes by CYTH1. This protein interacts with CYTH1 and SNX27 proteins and may act to sequester CYTH1 protein in the cytoplasm. [provided by RefSeq] Synonyms: B3-1; CASP; CYBR; CYTHIP; HE; PSCDBP This product is to be used for laboratory only. Not for diagnostic or therapeutic use. View online » ©2021 OriGene Technologies, Inc., 9620 Medical Center Drive, Ste 200, Rockville, MD 20850, US 1 / 2 PSCDBP (CYTIP) Rabbit Polyclonal Antibody – TA308371 Product images: Sample (30 ug of whole cell lysate).
    [Show full text]